169 related articles for article (PubMed ID: 34675114)
1. Clinical and Functional Significance of TP53 Exon 4-Intron 4 Splice Junction Variants.
Pinto EM; Maxwell KN; Halalsheh H; Phillips A; Powers J; MacFarland S; Walsh MF; Breen K; Formiga MN; Kriwacki R; Nichols KE; Mostafavi R; Wang J; Clay MR; Rodriguez-Galindo C; Ribeiro RC; Zambetti GP
Mol Cancer Res; 2022 Feb; 20(2):207-216. PubMed ID: 34675114
[TBL] [Abstract][Full Text] [Related]
2. A novel p.Gly187Arg TP53 variant appears to result in Li-Fraumeni syndrome.
Doyle MR; Johnston JM
Pediatr Hematol Oncol; 2018 Apr; 35(3):203-207. PubMed ID: 30239254
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set: An International Agency for Research on Cancer TP53 Database Analysis.
Kratz CP; Freycon C; Maxwell KN; Nichols KE; Schiffman JD; Evans DG; Achatz MI; Savage SA; Weitzel JN; Garber JE; Hainaut P; Malkin D
JAMA Oncol; 2021 Dec; 7(12):1800-1805. PubMed ID: 34709361
[TBL] [Abstract][Full Text] [Related]
4. Two TP53 germline mutations in a classical Li-Fraumeni syndrome family.
van Hest LP; Ruijs MW; Wagner A; van der Meer CA; Verhoef S; van't Veer LJ; Meijers-Heijboer H
Fam Cancer; 2007; 6(3):311-6. PubMed ID: 17318340
[TBL] [Abstract][Full Text] [Related]
5. Inherited germline TP53 mutation encodes a protein with an aberrant C-terminal motif in a case of pediatric adrenocortical tumor.
Pinto EM; Ribeiro RC; Kletter GB; Lawrence JP; Jenkins JJ; Wang J; Shurtleff S; McGregor L; Kriwacki RW; Zambetti GP
Fam Cancer; 2011 Mar; 10(1):141-6. PubMed ID: 20967502
[TBL] [Abstract][Full Text] [Related]
6. Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation.
Ferreira AM; Brondani VB; Helena VP; Charchar HLS; Zerbini MCN; Leite LAS; Hoff AO; Latronico AC; Mendonca BB; Diz MDPE; de Almeida MQ; Fragoso MCBV
J Steroid Biochem Mol Biol; 2019 Jun; 190():250-255. PubMed ID: 30974190
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study.
Wasserman JD; Novokmet A; Eichler-Jonsson C; Ribeiro RC; Rodriguez-Galindo C; Zambetti GP; Malkin D
J Clin Oncol; 2015 Feb; 33(6):602-9. PubMed ID: 25584008
[TBL] [Abstract][Full Text] [Related]
8. Recommended Guidelines for Validation, Quality Control, and Reporting of
Leroy B; Ballinger ML; Baran-Marszak F; Bond GL; Braithwaite A; Concin N; Donehower LA; El-Deiry WS; Fenaux P; Gaidano G; Langerød A; Hellstrom-Lindberg E; Iggo R; Lehmann-Che J; Mai PL; Malkin D; Moll UM; Myers JN; Nichols KE; Pospisilova S; Ashton-Prolla P; Rossi D; Savage SA; Strong LC; Tonin PN; Zeillinger R; Zenz T; Fraumeni JF; Taschner PE; Hainaut P; Soussi T
Cancer Res; 2017 Mar; 77(6):1250-1260. PubMed ID: 28254861
[TBL] [Abstract][Full Text] [Related]
9. Genetic and functional studies of a germline TP53 splicing mutation in a Li-Fraumeni-like family.
Varley JM; Chapman P; McGown G; Thorncroft M; White GR; Greaves MJ; Scott D; Spreadborough A; Tricker KJ; Birch JM; Evans DG; Reddel R; Camplejohn RS; Burn J; Boyle JM
Oncogene; 1998 Jun; 16(25):3291-8. PubMed ID: 9681828
[TBL] [Abstract][Full Text] [Related]
10. Characterization of germline TP53 splicing mutations and their genetic and functional analysis.
Varley JM; Attwooll C; White G; McGown G; Thorncroft M; Kelsey AM; Greaves M; Boyle J; Birch JM
Oncogene; 2001 May; 20(21):2647-54. PubMed ID: 11420676
[TBL] [Abstract][Full Text] [Related]
11. Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.
Lee DS; Yoon SY; Looi LM; Kang P; Kang IN; Sivanandan K; Ariffin H; Thong MK; Chin KF; Mohd Taib NA; Yip CH; Teo SH
Breast Cancer Res; 2012 Apr; 14(2):R66. PubMed ID: 22507745
[TBL] [Abstract][Full Text] [Related]
12. Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study.
Mouchawar J; Korch C; Byers T; Pitts TM; Li E; McCredie MR; Giles GG; Hopper JL; Southey MC
Cancer Res; 2010 Jun; 70(12):4795-800. PubMed ID: 20501846
[TBL] [Abstract][Full Text] [Related]
13. Compensatory relationship between splice sites and exonic splicing signals depending on the length of vertebrate introns.
Dewey CN; Rogozin IB; Koonin EV
BMC Genomics; 2006 Dec; 7():311. PubMed ID: 17156453
[TBL] [Abstract][Full Text] [Related]
14. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.
Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S;
JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041
[TBL] [Abstract][Full Text] [Related]
15. A novel
Xu F; Aref-Eshghi E; Wu J; Schubert J; Wertheim G; Bhatti T; Pogoriler J; Patel M; Cao K; Long A; Fan Z; Denenberg EH; Fanning EA; Wilmoth DM; Luo M; Conlin LK; Dain AS; Zelley K; Baldino S; Balamuth N; MacFarland S; Li MM; Zhong Y
Cold Spring Harb Mol Case Stud; 2022 Apr; 8(3):. PubMed ID: 35232817
[TBL] [Abstract][Full Text] [Related]
16. TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children.
Qian M; Cao X; Devidas M; Yang W; Cheng C; Dai Y; Carroll A; Heerema NA; Zhang H; Moriyama T; Gastier-Foster JM; Xu H; Raetz E; Larsen E; Winick N; Bowman WP; Martin PL; Mardis ER; Fulton R; Zambetti G; Borowitz M; Wood B; Nichols KE; Carroll WL; Pui CH; Mullighan CG; Evans WE; Hunger SP; Relling MV; Loh ML; Yang JJ
J Clin Oncol; 2018 Feb; 36(6):591-599. PubMed ID: 29300620
[TBL] [Abstract][Full Text] [Related]
17. A first report of a rare TP53 variant associated with Li-Fraumeni syndrome manifesting as invasive breast cancer and malignant solitary fibrous tumor.
Prejac J; Dedić Plavetić N; Gotovac Jerčić K; Borovečki F
World J Surg Oncol; 2021 Aug; 19(1):254. PubMed ID: 34452612
[TBL] [Abstract][Full Text] [Related]
18.
Terradas M; Mur P; Belhadj S; Woodward ER; Burghel GJ; Munoz-Torres PM; Quintana I; Navarro M; Brunet J; Lazaro C; Pineda M; Moreno V; Capella G; Evans DGR; Valle L
Gut; 2021 Jun; 70(6):1139-1146. PubMed ID: 32998877
[TBL] [Abstract][Full Text] [Related]
19. Less common genotype variants of TP53 polymorphisms are associated with poor outcome in adult patients with adrenocortical carcinoma.
Heinze B; Herrmann LJ; Fassnacht M; Ronchi CL; Willenberg HS; Quinkler M; Reisch N; Zink M; Allolio B; Hahner S
Eur J Endocrinol; 2014 May; 170(5):707-17. PubMed ID: 24566897
[TBL] [Abstract][Full Text] [Related]
20. Somatic intronic TP53 c.375+5G mutations are a recurrent but under-recognized mode of TP53 inactivation.
Chui MH; Yang C; Mehta N; Rai V; Zehir A; Momeni Boroujeni A; Ladanyi M; Mandelker D
J Pathol Clin Res; 2022 Jan; 8(1):14-18. PubMed ID: 34505757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
